
Spadrot MF 80mg/250mg Tablet
Marketer
Solace Biotech Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Spadrot MF 80mg/250mg Tablet
Alosec Duo 80mg/250mg tablets offer combined relief from abdominal distress. This medication effectively diminishes abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-signaling chemicals. Alosec Duo 80mg/250mg should be taken with food, following your doctor's prescribed dosage and duration. Your specific regimen will depend on your individual response and condition. Consistent use, as directed by your physician, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Dizziness and drowsiness are also potential effects; refrain from driving or activities requiring alertness until the medication's impact is understood. Alcohol consumption should be avoided due to potential dizziness intensification. Prior to commencing treatment, inform your doctor of pregnancy, pregnancy plans, or breastfeeding. Kidney or liver conditions should also be disclosed to ensure appropriate dosage.
Primary Ingredients of Spadrot MF 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Spadrot MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Spadrot MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or breaking it. The Spadrot MF 80mg/250mg Tablet should be taken with a meal.
Common Side effects of Spadrot MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Spadrot MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Spadrot MF 80mg/250mg Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Spadrot MF 80mg/250mg Tablet works:
Each Spadrot MF 80mg/250mg tablet unites Drotaverine and Mefenamic Acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal smooth muscle contractions. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Spadrot MF 80mg/250mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Spadrot MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Spadrot MF 80mg/250mg Tablet with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking Spadrot MF 80mg/250mg tablets might lead to adverse reactions, potentially impairing driving ability due to the possibility of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Spadrot MF 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Spadrot MF 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Spadrot MF 80mg/250mg tablets. Dosage modifications for Spadrot MF 80mg/250mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Spadrot MF 80mg/250mg Tablet :
Should you forget to take your Spadrot MF 80mg/250mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spadrot MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
